IMPURITIES AVAILABLE FOR 'Bosutinib Monohydrate'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Bosutinib Monohydrate. Bosutinib Monohydrate is the hydrated form of bosutinib, an oral tyrosine kinase inhibitor (TKI) used in the treatment of chronic myelogenous leukemia (CML), particularly in patients who are resistant or intolerant to prior TKI therapy. It selectively inhibits the BCR-ABL kinase, the abnormal fusion protein driving CML, along with SRC-family kinases, disrupting cancer cell proliferation and survival. Bosutinib monohydrate enhances the solubility and stability of the active compound for effective oral administration. It is generally taken once daily with food. Common side effects include diarrhea, nausea, elevated liver enzymes, fatigue, and rash. Liver function and blood counts should be monitored during treatment. Dose adjustments may be needed in patients with hepatic or renal impairment. It is contraindicated in pregnancy and should be used with caution in individuals with cardiovascular risk. Buy high quality Bosutinib Monohydrate from Omsynth Lifesciences.